Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04534491 · ClinicalTrials.gov registry record · Phase 3
Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 855
- Enrollment target
NCT04534491 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 855 participants.
The verdict
NCT04534491, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 855 participants
- Enrollment target
Study Summary
With this study researchers want to gather information about the consumer use behavior of Oxytrol in a simulated setting in which the medicine is sold directly to a consumer without a prescription from a healthcare professional. An area of focus was on the potential benefits of an over-the-counter status for Oxytrol and on the ongoing use behavior of the consumers. Oxytrol is a thin, flexible, clear patch that is indicated for the treatment of overactive bladder a disease characterized by a collection of symptoms, including urinary frequency, urgency, and urge incontinence. The adhesive patch is placed on the skin to deliver Oxytrol through the skin into the bloodstream.
Interventions
- DRUG Oxybutynin (Oxytrol, BAY839380)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 855 participants |
| Start Date | 2010-05-25 |
| Est. Completion | 2011-06-22 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04534491
The ClinicalTrials.gov registry entry for NCT04534491 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 855 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxybutynin (Oxytrol, BAY839380) is the first listed.
NCT04534491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04534491 about?
NCT04534491 is a clinical study titled "Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.". With this study researchers want to gather information about the consumer use behavior of Oxytrol in a simulated setting in which the medicine is sold directly to a consumer without a prescription from a healthcare professional. An area of focus was on the potential benefits of an over-the-counter s...
What is the current status of trial NCT04534491?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 855 participants. The study started on 2010-05-25. Estimated completion is 2011-06-22.
What interventions are being tested in trial NCT04534491?
The interventions under investigation include: Oxybutynin (Oxytrol, BAY839380) (DRUG).
Who is sponsoring clinical trial NCT04534491?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.